Dengue vaccine
Kathryn Dzintars, PharmD, BCPS
VACCINE TYPE
VACCINE TYPE
VACCINE TYPE
- Dengvaxia®, or the Dengue Tetravalent Vaccine, is a live, attenuated vaccine active against dengue virus serotypes 1, 2, 3 and 4.
- Approved for use in individuals 9 through 16 years of age with laboratory-confirmed previous dengue infection AND who lived in an endemic area.
- The vaccine is built on a yellow fever backbone component.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2024 Unbound Medicine, Inc. All rights reserved